Am. J. Respir. Crit. Care Med., Volume 158, Number 1, July 1998, 115-120

A Placebo-controlled Trial of a HEPA Air Cleaner in the Treatment of Cat Allergy

ROBERT A. WOOD, ELIZABETH F. JOHNSON, MARK L. VAN NATTA, PEI HUA CHEN, and PEYTON A. EGGLESTON

Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University School of Medicine; and Department of Epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland

To evaluate the effect of a room high-efficiency particulate air (HEPA) cleaner on cat-induced asthma and rhinitis, 35 cat-allergic subjects who were living with one or more cats were studied in a double-blind, placebo controlled trial. After a 1 mo baseline period, subjects' bedrooms were equipped with an active or placebo air cleaner for the following 3 mo. Evaluations included monthly measurement of cat-allergen levels, daily morning, afternoon, and nighttime nasal- and chest-symptom scores, twice-daily measurement of peak-flow rates, daily medication scores, monthly spirometry, and methacholine (MCh) challenge testing before and after the study. Airborne allergen levels were reduced in the active-filter group as compared with the placebo group (p = 0.045). However, no differences were detected in settled-dust allergen levels (p = 0.485), morning, afternoon, or nighttime nasal-symptom scores (p = 0.769, 0.534, and 0.138), chest-symptom scores (p = 0.388, 0.179, and 0.215), sleep disturbance (p = 0.101), morning or afternoon peak-flow rates (p = 0.424 and 0.679), or rescue medication use (nasal, p = 0.164, chest, p = 0.650), respectively. Although the combination of a HEPA room air cleaner, mattress and pillow covers, and cat exclusion from the bedroom did reduce airborne cat-allergen levels, no effect on disease activity was detected for any parameter studied.

This article has been cited by other articles:

				Y. Wang, B. S. Maciejewski, N. Lee, O. Silbert, N. L. McKnight, J. A. Frangos, and J. Sanchez-Esteban Strain-induced fetal type II epithelial cell differentiation is mediated via cAMP-PKA-dependent signaling pathway Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L820 - L827. [Abstract] [Full Text] [PDF]

				P A Beckett and P H Howarth Pharmacotherapy and airway remodelling in asthma? Thorax, February 1, 2003; 58(2): 163 - 174. [Abstract] [Full Text] [PDF]

				P. Ernst Environmental Measures and Asthma Chest, November 1, 2002; 122(5): 1509 - 1510. [Full Text] [PDF]

				L. J. Janssen Ionic mechanisms and Ca2+ regulation in airway smooth muscle contraction: do the data contradict dogma? Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1161 - L1178. [Abstract] [Full Text] [PDF]

				D. Xu, C. Isaacs, I. P. Hall, and C. W. Emala Human airway smooth muscle expresses 7 isoforms of adenylyl cyclase: a dominant role for isoform V Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L832 - L843. [Abstract] [Full Text] [PDF]

				D. W. McGraw, S. L. Forbes, L. A. Kramer, D. P. Witte, C. N. Fortner, R. J. Paul, and S. B. Liggett Transgenic Overexpression of beta 2-Adrenergic Receptors in Airway Smooth Muscle Alters Myocyte Function and Ablates Bronchial Hyperreactivity J. Biol. Chem., November 5, 1999; 274(45): 32241 - 32247. [Abstract] [Full Text] [PDF]

				S. B. Liggett Plastic Adenylyl Cyclase Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 564 - 566. [Full Text]